MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 28,837
- Price
- $7.13
- Value
- $205,608
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•42 filings
TRDA
Entrada Therapeutics, Inc.
Net sales of $10.3M over the last 3 months
20 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$10,325,761
0 buyers · 20 sellers
12-month purchases
$1,643,749
5 distinct insiders
12-month sales
$15,103,872
23 distinct insiders
Highlighted alerts
52
9 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get TRDA insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
TRDA overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
93
Raw transactions
Everything returned by the filing
61
Voluntary view
P/S trades after deterministic checks
32
Administrative noise
Stored, never alerted
11
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 2,079
- Price
- $7.14
- Footnotes
- 2
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations. The sale does not represent a discretionary trade by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 28,837
- Price
- $7.13
- Value
- $205,608
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 192,500
- Price
- $7.41
- Value
- $1,426,425
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 192,500
- Price
- $7.41
- Value
- $1,426,425
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 38,500
- Price
- $7.11
- Value
- $273,735
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 38,500
- Price
- $7.11
- Value
- $273,735
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 32,263
- Price
- $7.17
- Value
- $231,326
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 32,263
- Price
- $7.17
- Value
- $231,326
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 25,131
- Price
- $7.19
- Value
- $180,692
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 25,131
- Price
- $7.19
- Value
- $180,692
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 29,088
- Price
- $7.06
- Value
- $205,361
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 29,088
- Price
- $7.06
- Value
- $205,361
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 44,259
- Price
- $6.99
- Value
- $309,370
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 44,259
- Price
- $6.99
- Value
- $309,370
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 3,733
- Price
- $7.01
- Value
- $26,168
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 3,733
- Price
- $7.01
- Value
- $26,168
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 38,922
- Price
- $7.20
- Value
- $280,238
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 38,922
- Price
- $7.20
- Value
- $280,238
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 14,569
- Price
- $7.06
- Value
- $102,857
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 14,569
- Price
- $7.06
- Value
- $102,857
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 26,522
- Price
- $7.54
- Value
- $199,976
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 26,522
- Price
- $7.54
- Value
- $199,976
MPM BioVentures 2014, L.P.
10% owner
SaleAlert
- Shares
- 21,623
- Price
- $7.34
- Value
- $158,713
MPM BIOVENTURES 2018, L.P.
10% owner
SaleAlert
- Shares
- 21,623
- Price
- $7.34
- Value
- $158,713
PARMAR KUSH
Director
SaleAlert
- Shares
- 92,444
- Price
- $7.00
- Value
- $647,108
PARMAR KUSH
Director
SaleAlert
- Shares
- 52,317
- Price
- $6.85
- Value
- $358,371
5AM Ventures V, L.P.
10% owner
SaleAlert
- Shares
- 52,317
- Price
- $6.85
- Value
- $358,371
PARMAR KUSH
Director
SaleAlert
- Shares
- 10,494
- Price
- $7.00
- Value
- $73,458
5AM Ventures V, L.P.
10% owner
SaleAlert
- Shares
- 10,494
- Price
- $7.00
- Value
- $73,458
PARMAR KUSH
Director
SaleAlert
- Shares
- 1,718
- Price
- $6.85
- Value
- $11,768
5AM Ventures V, L.P.
10% owner
SaleAlert
- Shares
- 1,718
- Price
- $6.85
- Value
- $11,768
PARMAR KUSH
Director
SaleAlert
- Shares
- 114,756
- Price
- $6.93
- Value
- $795,259
5AM Ventures V, L.P.
10% owner
SaleAlert
- Shares
- 114,756
- Price
- $6.93
- Value
- $795,259
Zeiher Bernhardt G
Director
PurchaseAlert
- Shares
- 5,000
- Price
- $5.86
- Value
- $29,316
Sethuraman Natarajan
President, Research & Develop.
Sale 10b5-1
- Shares
- 25,907
- Price
- $15.39
- Value
- $398,810
Dowden Nathan J
President & COO
Sale 10b5-1
- Shares
- 15,000
- Price
- $15.33
- Value
- $229,953
WENTWORTH KORY JAMES
Chief Financial Officer
Sale 10b5-1
- Shares
- 2,500
- Price
- $12.95
- Value
- $32,375
Dowden Nathan J
President & COO
Sale 10b5-1
- Shares
- 11,894
- Price
- $13.05
- Value
- $155,188
WENTWORTH KORY JAMES
Chief Financial Officer
Sale 10b5-1
- Shares
- 11,388
- Price
- $13.02
- Value
- $148,216
Dowden Nathan J
President & COO
Sale 10b5-1
- Shares
- 3,116
- Price
- $13.02
- Value
- $40,583
WENTWORTH KORY JAMES
Chief Financial Officer
Sale 10b5-1
- Shares
- 5,089
- Price
- $13.00
- Value
- $66,163
WENTWORTH KORY JAMES
Chief Financial Officer
Sale 10b5-1
- Shares
- 7,988
- Price
- $12.25
- Value
- $97,892
WENTWORTH KORY JAMES
Chief Financial Officer
Sale 10b5-1
- Shares
- 8,910
- Price
- $9.98
- Value
- $88,932
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 13,082
- Price
- $9.07
- Value
- $118,690
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 1,186
- Price
- $9.07
- Value
- $10,760
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 13,386
- Price
- $9.07
- Value
- $121,395
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 1,213
- Price
- $9.07
- Value
- $11,000
PARMAR KUSH
Director
SaleAlert
- Shares
- 200,000
- Price
- $8.80
- Value
- $1,760,000
5AM Ventures V, L.P.
10% owner
SaleAlert
- Shares
- 200,000
- Price
- $8.80
- Value
- $1,760,000
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 80,881
- Price
- $7.73
- Value
- $625,331
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 7,321
- Price
- $7.73
- Value
- $56,602
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 11,494
- Price
- $7.95
- Value
- $91,431
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 1,040
- Price
- $7.95
- Value
- $8,273
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 30,879
- Price
- $7.54
- Value
- $232,812
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 2,795
- Price
- $7.54
- Value
- $21,073
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 11,701
- Price
- $7.39
- Value
- $86,481
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 1,059
- Price
- $7.39
- Value
- $7,827
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 2,947
- Price
- $7.22
- Value
- $21,290
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 267
- Price
- $7.22
- Value
- $1,929
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 25,364
- Price
- $7.21
- Value
- $182,973
BAKER BROS. ADVISORS LP
10% owner
PurchaseAlert
- Shares
- 2,296
- Price
- $7.21
- Value
- $16,563
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 09, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 28,837 | $7.13 | $205,608 | |
| Sep 09, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 28,837 | $7.13 | $205,608 | |
| Sep 08, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 192,500 | $7.41 | $1,426,425 | |
| Sep 08, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 192,500 | $7.41 | $1,426,425 | |
| Sep 04, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 38,500 | $7.11 | $273,735 | |
| Sep 04, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 38,500 | $7.11 | $273,735 | |
| Sep 03, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 32,263 | $7.17 | $231,326 | |
| Sep 03, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 32,263 | $7.17 | $231,326 | |
| Sep 02, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 25,131 | $7.19 | $180,692 | |
| Sep 02, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 25,131 | $7.19 | $180,692 | |
| Sep 01, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 29,088 | $7.06 | $205,361 | |
| Sep 01, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 29,088 | $7.06 | $205,361 | |
| Aug 31, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 44,259 | $6.99 | $309,370 | |
| Aug 31, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 44,259 | $6.99 | $309,370 | |
| Aug 28, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 3,733 | $7.01 | $26,168 | |
| Aug 28, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 3,733 | $7.01 | $26,168 | |
| Aug 27, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 38,922 | $7.20 | $280,238 | |
| Aug 27, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 38,922 | $7.20 | $280,238 | |
| Aug 26, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 14,569 | $7.06 | $102,857 | |
| Aug 26, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 14,569 | $7.06 | $102,857 | |
| Aug 25, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 26,522 | $7.54 | $199,976 | |
| Aug 25, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 26,522 | $7.54 | $199,976 | |
| Aug 24, 2026 | MPM BioVentures 2014, L.P. 10% owner | Sale | 21,623 | $7.34 | $158,713 | |
| Aug 24, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Sale | 21,623 | $7.34 | $158,713 | |
| Aug 10, 2026 | PARMAR KUSH Director | Sale | 92,444 | $7.00 | $647,108 | |
| Aug 07, 2026 | PARMAR KUSH Director | Sale | 52,317 | $6.85 | $358,371 | |
| Aug 07, 2026 | 5AM Ventures V, L.P. 10% owner | Sale | 52,317 | $6.85 | $358,371 | |
| Aug 06, 2026 | PARMAR KUSH Director | Sale | 10,494 | $7.00 | $73,458 | |
| Aug 06, 2026 | 5AM Ventures V, L.P. 10% owner | Sale | 10,494 | $7.00 | $73,458 | |
| Jul 31, 2026 | PARMAR KUSH Director | Sale | 1,718 | $6.85 | $11,768 | |
| Jul 31, 2026 | 5AM Ventures V, L.P. 10% owner | Sale | 1,718 | $6.85 | $11,768 | |
| Jul 30, 2026 | PARMAR KUSH Director | Sale | 114,756 | $6.93 | $795,259 | |
| Jul 30, 2026 | 5AM Ventures V, L.P. 10% owner | Sale | 114,756 | $6.93 | $795,259 | |
| May 20, 2026 | Zeiher Bernhardt G Director | Purchase | 5,000 | $5.86 | $29,316 | |
| May 04, 2026 | Sethuraman Natarajan President, Research & Develop. | Sale | 25,907 | $15.39 | $398,810 | |
| May 04, 2026 | Dowden Nathan J President & COO | Sale | 15,000 | $15.33 | $229,953 | |
| Apr 01, 2026 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | 2,500 | $12.95 | $32,375 | |
| Mar 10, 2026 | Dowden Nathan J President & COO | Sale | 11,894 | $13.05 | $155,188 | |
| Mar 10, 2026 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | 11,388 | $13.02 | $148,216 | |
| Mar 09, 2026 | Dowden Nathan J President & COO | Sale | 3,116 | $13.02 | $40,583 | |
| Mar 09, 2026 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | 5,089 | $13.00 | $66,163 | |
| Mar 04, 2026 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | 7,988 | $12.25 | $97,892 | |
| Nov 21, 2025 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | 8,910 | $9.98 | $88,932 | |
| Nov 20, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 13,082 | $9.07 | $118,690 | |
| Nov 20, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 1,186 | $9.07 | $10,760 | |
| Nov 20, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 13,386 | $9.07 | $121,395 | |
| Nov 20, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 1,213 | $9.07 | $11,000 | |
| Nov 14, 2025 | PARMAR KUSH Director | Sale | 200,000 | $8.80 | $1,760,000 | |
| Nov 14, 2025 | 5AM Ventures V, L.P. 10% owner | Sale | 200,000 | $8.80 | $1,760,000 | |
| Nov 12, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 80,881 | $7.73 | $625,331 | |
| Nov 12, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 7,321 | $7.73 | $56,602 | |
| Nov 12, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 11,494 | $7.95 | $91,431 | |
| Nov 12, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 1,040 | $7.95 | $8,273 | |
| Nov 11, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 30,879 | $7.54 | $232,812 | |
| Nov 11, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 2,795 | $7.54 | $21,073 | |
| Nov 11, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 11,701 | $7.39 | $86,481 | |
| Nov 11, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 1,059 | $7.39 | $7,827 | |
| Nov 10, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 2,947 | $7.22 | $21,290 | |
| Nov 10, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 267 | $7.22 | $1,929 | |
| Nov 10, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 25,364 | $7.21 | $182,973 | |
| Nov 10, 2025 | BAKER BROS. ADVISORS LP 10% owner | Purchase | 2,296 | $7.21 | $16,563 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.